ArticleTargeted oncology2018

Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane.

Annelieke E C A B Willemsen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.